Disposable Syringes Market (By Type: Conventional Syringes, Retractable Safety Syringes, Safety Syringes, and Non-retractable Safety Syringes; By Application: Immunization Injections and Therapeutic Injections) - Global Industry Analysis, Market Size, Share, Growth, Trends, Regional Outlook And Segment Forecasts 2024 - 2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Covid-19: Disposable Syringes Industry Impact
5.2. Disposable Syringes Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Disposable Syringes Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Disposable Syringes Market Players to deal with Covid-19 Pandemic Scenario
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing patient awareness
6.1.1.2. Increased health care expenditure
6.1.2. Market Restraints
6.1.2.1. High cost
6.1.3. Market Opportunities
6.1.3.1. Large pool of geriatric population
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Disposable Syringes Market Revenue by Market Players
7.1.1.2. Disposable Syringes Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
8.1. Disposable Syringes Market, by Type, 2024-2033
8.1.1. Conventional Syringes
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Safety Syringes
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Retractable Safety Syringes
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Non-Retractable Safety Syringes
8.1.4.1. Market Revenue and Forecast (2021-2033)
9.1. Disposable Syringes Market, by Application, 2024-2033
9.1.1. Immunization Injections
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Therapeutic Injections
9.1.2.1. Market Revenue and Forecast (2021-2033)
10.1. North America
10.1.1. Market Revenue Forecast by Type(2021-2033)
10.1.2. Market Revenue Forecast by Application (2021-2033)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2021-2033)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2021-2033)
10.2. Europe
10.2.1. Market Revenue Forecast by Type (2021-2033)
10.2.2. Market Revenue Forecast by Application (2021-2033)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2021-2033)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2021-2033)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2021-2033)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2021-2033)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Type (2021-2033)
10.3.2. Market Revenue Forecast by Application (2021-2033)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2021-2033)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2021-2033)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2021-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2021-2033)
10.4. LATAM
10.4.1. Market Revenue Forecast by Type (2021-2033)
10.4.2. Market Revenue Forecast by Application (2021-2033)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2021-2033)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2021-2033)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Type (2021-2033)
10.5.2. Market Revenue Forecast by Application (2021-2033)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2021-2033)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2021-2033)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2021-2033)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2021-2033)
11.1. Fresenius Kabi AG
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Type Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin
11.1.4. Recent Developments and Strategies
11.2. Becton, Dickinson and Company
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Type Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin
11.2.4. Recent Developments and Strategies
11.3. Flextronics International
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Type Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin
11.3.4. Recent Developments and Strategies
11.4. Covidien
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Type Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin
11.4.4. Recent Developments and Strategies
11.5. Braun Medical, Inc.
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Type Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin
11.5.4. Recent Developments and Strategies
11.6. Novo Nordisk
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Type Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin
11.6.4. Recent Developments and Strategies
11.7. Vita Needle Company
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Type Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin
11.7.4. Recent Developments and Strategies
11.8. Baxter International, Inc.
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Type Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin
11.8.4. Recent Developments and Strategies
11.9. Retractable Technologies, Inc.
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Type Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin
11.9.4. Recent Developments and Strategies
11.10. Henke-Sass, Wolf
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Type Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin
11.10.4. Recent Developments and Strategies
11.11. UltiMed, Inc.
11.11.1. Company Overview, Business Information, Regional Presence
11.11.2. Product Portfolio Analysis
11.11.2.1. Type Details, Specification, Application
11.11.3. Revenue, Price, and Gross Margin
11.11.4. Recent Developments and Strategies
11.12. Terumo Corporation
11.12.1. Company Overview, Business Information, Regional Presence
11.12.2. Product Portfolio Analysis
11.12.2.1. Type Details, Specification, Application
11.12.3. Revenue, Price, and Gross Margin
11.12.4. Recent Developments and Strategies
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client